Ares Commercial Real Estate Corp
For the period ended Dec 31, 2025. Filed Feb 10, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 10, 2026
ACRE$3.56-3.3%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets as of December 31, 202 and
CONSOLIDATED BALANCE SHEETS
| As of December 31, | ||
|---|---|---|
| 2025 | 2024 | |
| ASSETS | ||
| Cash and cash equivalents | $29,289 | $63,799 |
| Restricted cash ($1,108 and $2,495 related to consolidated VIEs, respectively) | 37,868 | 2,495 |
| Loans held for investment ($138,950 and $551,955 related to consolidated VIEs, respectively) | 1,528,806 | 1,656,688 |
| Current expected credit loss reserve | (125,756) | (136,224) |
| Loans held for investment, net of current expected credit loss reserve | 1,403,050 | 1,520,464 |
| Investment in available-for-sale debt securities, at fair value | — | 8,684 |
| Real estate owned held for investment, net ($52,634 and $58,844 related to consolidated VIEs, respectively) | 130,165 | 139,032 |
| Other assets ($76 and $1,991 of interest receivable related to consolidated VIEs, respectively) | 17,770 | 16,732 |
| Total assets | $1,618,142 | $1,751,206 |
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||
| LIABILITIES | ||
| Secured funding agreements | $858,176 | $588,468 |
| Secured term loan | 89,360 | 128,062 |
| Collateralized loan obligation securitization debt (consolidated VIEs) | 99,921 | 455,839 |
| Due to affiliate | 4,061 | 3,790 |
| Dividends payable | 8,442 | 13,924 |
| Other liabilities ($257 and $1,309 of interest payable related to consolidated VIEs, respectively) | 48,614 | 20,991 |
| Total liabilities | 1,108,574 | 1,211,074 |
| Commitments and contingencies (Note 8) | ||
| STOCKHOLDERS' EQUITY | ||
| Common stock, par value $0.01 per share, 450,000,000 shares authorized at December 31, 2025 and 2024 and 55,026,453 and 54,542,178 shares issued and outstanding at December 31, 2025 and 2024, respectively | 532 | 532 |
| Additional paid-in capital | 820,827 | 816,923 |
| Accumulated other comprehensive income (loss) | — | 37 |
| Accumulated earnings (deficit) | (311,791) | (277,360) |
| Total stockholders' equity | 509,568 | 540,132 |
| Total liabilities and stockholders' equity | $1,618,142 | $1,751,206 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.